Autopsy report · NCT03686514

The Impact of Imprinting and Repeated Influenza Vaccination on Adaptive Immunity, Transcriptomics, and Metabolomics

“The study closed prior to completing year 3 of the study due to the COVID-19 pandemic.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 8 months before it stopped.
• 39 participants enrolled.
• Results were posted on the registry 2 years 1 month after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Emory University

Sponsor type

University, hospital or other

Conditions

Influenza

Interventions

FLUARIX QUADRIVALENT

Participants

39

Sites

1

Countries

United States

Trials that died the same way

• RES Prepared With RECELL® Compared to Conventional Care for Healing of Donor Sites in Ages 1-16 Years
  “Study closed in response to COVID-19 and overall program objectives.” (84% match in meaning)
• Camp Based Multi-component Intervention for Families of Young Children With Type 1 Diabetes
  “Study terminated due to COVID-19 pandemic” (81% match in meaning)
• The Efficacy of Denosumab in Incomplete Patients Spinal Cord Injury
  “Study ended early due to COVID-19” (81% match in meaning)
• Optune Device - TT Field Plus Nivolumab and Ipilimumab for Melanoma With Brain Metastasis
  “The study was terminated early on 03/09/2022 due to low accrual during the COVID-19 pandemic.” (79% match in meaning)
• Effects of Community-center Based Dietary Intervention on Frailty Prevention and Regression in the Elderly.
  “Due to the impacts of COVID-19, the study had to terminate.” (79% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.